Gene Biotherapeutics, Inc. Earnings Per Share, Basic and Diluted
Gene Biotherapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.02 per share for the 12-month period ending 2020-12-31, per its 10-K/A filed 2022-04-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-04-14
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.01.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.01.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.01.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$0.02.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.02, a 140.00% decline from fiscal 2019.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was $0.05.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.03.
- Gene Biotherapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.13.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$0.02 10-K/A · filed 2022-04-14 | |||||||
| 2020-09-30 | -$0.01 10-Q · filed 2021-10-27 | -$0.00 10-Q · filed 2021-10-27 | ||||||
| 2020-03-31 | -$0.01 10-Q · filed 2021-09-03 | |||||||
| 2019-12-31 | $0.05 10-K/A · filed 2022-04-14 | |||||||
| 2019-09-30 | -$0.01 10-Q · filed 2021-10-27 | -$0.04 10-Q · filed 2021-10-27 | ||||||
| 2019-03-31 | -$0.02 10-Q · filed 2021-09-03 | |||||||
| 2018-12-31 | -$0.03 10-K · filed 2021-04-23 | |||||||
| 2017-12-31 | -$0.13 10-K · filed 2021-04-23 | |||||||
| 2017-03-31 | -$0.04 10-Q · filed 2017-07-28 | |||||||
| 2016-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2017-07-28 | -$0.20 derived: net income ÷ weighted average shares · filed 2017-07-28 | -$0.28 10-K · filed 2017-07-28 | |||||
| 2016-09-30 | -$0.14 10-Q · filed 2017-03-21 | -$0.21 10-Q · filed 2017-03-21 | ||||||
| 2016-06-30 | -$0.05 10-Q · filed 2017-03-06 | -$0.08 10-Q · filed 2017-03-06 | ||||||
| 2016-03-31 | -$0.03 10-Q · filed 2017-07-28 | |||||||
| 2015-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2017-07-28 | -$0.18 derived: net income ÷ weighted average shares · filed 2017-07-28 | -$0.34 10-K · filed 2017-07-28 | |||||
| 2015-09-30 | -$0.14 10-Q · filed 2017-03-21 | -$0.30 10-Q · filed 2017-03-21 | ||||||
| 2015-06-30 | -$0.11 10-Q · filed 2017-03-06 | -$0.16 10-Q · filed 2017-03-06 | ||||||
| 2015-03-31 | -$0.05 10-Q · filed 2017-03-01 | |||||||
| 2014-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2016-12-29 | -$0.25 derived: net income ÷ weighted average shares · filed 2016-12-29 | -$0.34 derived: net income ÷ weighted average shares · filed 2016-12-29 | -$0.50 10-K · filed 2016-12-29 | ||||
| 2014-09-30 | -$0.12 10-Q · filed 2016-10-27 | -$0.21 derived: net income ÷ weighted average shares · filed 2016-10-27 | -$0.36 10-Q · filed 2016-10-27 | |||||
| 2014-06-30 | -$0.09 10-Q · filed 2016-08-29 | -$0.24 10-Q · filed 2016-08-29 | ||||||
| 2014-03-31 | -$0.16 10-Q · filed 2015-06-18 | |||||||
| 2013-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2015-05-22 | -$0.62 derived: net income ÷ weighted average shares · filed 2015-05-22 | -$0.98 derived: net income ÷ weighted average shares · filed 2015-05-22 | -$1.33 10-K · filed 2015-05-22 | ||||
| 2013-09-30 | -$0.28 10-Q · filed 2014-11-19 | -$0.64 derived: net income ÷ weighted average shares · filed 2014-11-19 | -$0.99 10-Q · filed 2014-11-19 | |||||
| 2013-06-30 | -$0.37 10-Q · filed 2014-08-12 | -$0.72 10-Q · filed 2014-08-12 | ||||||
| 2013-03-31 | -$0.35 10-Q · filed 2014-05-15 | -$0.02 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2014-04-15 | -$0.63 derived: net income ÷ weighted average shares · filed 2014-04-15 | -$0.94 derived: net income ÷ weighted average shares · filed 2014-04-15 | -$1.41 10-K · filed 2014-04-15 | -$0.07 10-K · filed 2013-04-05 | |||
| 2012-09-30 | -$0.32 10-Q · filed 2013-11-19 | -$0.02 10-Q · filed 2012-11-14 | -$0.63 derived: net income ÷ weighted average shares · filed 2013-11-19 | -$1.10 10-Q · filed 2013-11-19 | -$0.05 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | -$0.31 10-Q · filed 2013-08-14 | -$0.02 10-Q · filed 2012-08-14 | -$0.78 10-Q · filed 2013-08-14 | -$0.04 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | -$0.02 10-Q · filed 2013-05-15 | |||||||
| 2011-12-31 | -$0.08 10-K · filed 2013-04-05 | |||||||
| 2011-09-30 | -$0.02 10-Q · filed 2012-11-14 | -$0.06 10-Q · filed 2012-11-14 | ||||||
| 2011-06-30 | -$0.02 10-Q · filed 2012-08-14 | -$0.04 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$0.02 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | -$0.06 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | -$0.04 10-Q · filed 2011-11-14 | -$0.07 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-15 | -$0.03 10-Q · filed 2011-08-15 |